On the basis of these results, the researchers propose a molecular stratification of glioblastoma consisting of four clinically relevant tumor subtypes—classical, mesenchymal, proneural and neural.

Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.